UBS AM’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
149,740
+33,917
| +29% | +$443K | ﹤0.01% | 2151 |
|
|
2025
Q1 | $1.72M | Buy |
115,823
+8,490
| +8% | +$126K | ﹤0.01% | 2059 |
|
|
2024
Q4 | $1.95M | Buy |
107,333
+7,278
| +7% | +$132K | ﹤0.01% | 2060 |
|
|
2024
Q3 | $1.34M | Sell |
100,055
-3,118
| -3% | -$41.9K | ﹤0.01% | 2234 |
|
|
2024
Q2 | $1.43M | Buy |
103,173
+39,693
| +63% | +$549K | ﹤0.01% | 2181 |
|
|
2024
Q1 | $1.19M | Hold |
63,480
| – | – | ﹤0.01% | 1923 |
|
|
2023
Q4 | $1.44M | Buy |
63,480
+3,042
| +5% | +$68.9K | ﹤0.01% | 1836 |
|
|
2023
Q3 | $1.5M | Sell |
60,438
-3,480
| -5% | -$86.3K | ﹤0.01% | 1758 |
|
|
2023
Q2 | $1.43M | Hold |
63,918
| – | – | ﹤0.01% | 1839 |
|
|
2023
Q1 | $1.43M | Buy |
63,918
+3,574
| +6% | +$79.8K | ﹤0.01% | 1839 |
|
|
2022
Q4 | $1.6M | Sell |
60,344
-5,683
| -9% | -$151K | ﹤0.01% | 1638 |
|
|
2022
Q3 | $1.87M | Buy |
66,027
+4,786
| +8% | +$136K | ﹤0.01% | 1633 |
|
|
2022
Q2 | $1.28M | Buy |
61,241
+22,321
| +57% | +$465K | ﹤0.01% | 1831 |
|
|
2022
Q1 | $843K | Buy |
38,920
+13,752
| +55% | +$298K | ﹤0.01% | 2228 |
|
|
2021
Q4 | $699K | Buy |
+25,168
| New | +$699K | ﹤0.01% | 2395 |
|
|
2020
Q2 | – | Sell |
-11,776
| Closed | -$79.4K | – | 2477 |
|
|
2020
Q1 | $79.4K | Sell |
11,776
-11,640
| -50% | -$78.5K | ﹤0.01% | 2412 |
|
|
2019
Q4 | $272K | Buy |
+23,416
| New | +$272K | ﹤0.01% | 2392 |
|
|
2018
Q1 | – | Sell |
-10,900
| Closed | -$139K | – | 2657 |
|
|
2017
Q4 | $139K | Hold |
10,900
| – | – | ﹤0.01% | 2365 |
|
|
2017
Q3 | $155K | Hold |
10,900
| – | – | ﹤0.01% | 2314 |
|
|
2017
Q2 | $141K | Hold |
10,900
| – | – | ﹤0.01% | 2301 |
|
|
2017
Q1 | $157K | Hold |
10,900
| – | – | ﹤0.01% | 2244 |
|
|
2016
Q4 | $170K | Sell |
10,900
-14,600
| -57% | -$228K | ﹤0.01% | 2162 |
|
|
2016
Q3 | $300K | Buy |
25,500
+3,900
| +18% | +$45.9K | ﹤0.01% | 2263 |
|
|
2016
Q2 | $301K | Hold |
21,600
| – | – | ﹤0.01% | 2222 |
|
|
2016
Q1 | $251K | Buy |
21,600
+1,300
| +6% | +$15.1K | ﹤0.01% | 2307 |
|
|
2015
Q4 | $333K | Buy |
+20,300
| New | +$333K | ﹤0.01% | 2290 |
|